BioSpace News Archive

AXON NEUROSCIENCE SE announced it will present new results from its Phase II clinical study of its tau vaccine AADvac1 against Alzheimer’s disease at the 2021 Alzheimer’s Association International Conference, which is being held in Denver, Colorado and virtually, 26th - 30th July.

Releviate™ Therapeutics, a bio-pharmaceutical company developing a novel human antibody-based approach to treating neuropathic pain by potentially reversing the underlying pathophysiology of that pain, today appoints Dr. Steven P. Cohen to lead its scientific advisory board.

MezLight LLC is excited to announce the launch of their revolutionary surgical lighting system to provide surgeons with a bright, sterile, and reusable solution for focused light.

Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology, today announced the appointment of Anand Varadan to its Board of Directors, effective July 26, 2021.

Hyloris Pharmaceuticals SA, a specialty biopharma company committed to addressing unmet medical needs through reinventing existing medications, announces that it will host a conference call and audio webcast on Wednesday, 4 August 2021 at 3:00 pm CEST to present its half-year 2021 financial results and to provide a business update.

Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that David Zaccardelli, Pharm. D., President and Chief Executive Officer, will present at the following virtual investor conferences in August 2021

Ultrasound devices enable physicians to image internal organs of a patient’s body in order to diagnose diseases. They help surgeons by guiding movement of surgical instruments during surgeries.

The healthcare segment has undergone a tremendous change with deployment of robotics for several types of surgeries.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global infrared thermometer market is expected to rise at an impressive rate owing to the surge in COVID-19 cases across the globe.

Samsung Biologics, the world’s leading contract development and manufacturing organization, announced strong financial results for the second quarter of fiscal 2021.